← back to search

Xingming Jiang

Harbin Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, Cholangiocarcinoma and Gallbladder Cancer Studies, Circular RNAs in diseases, and RNA modifications and cancer.
h-index
29
citations
2,528
works
77
NIH funding
primary concept
Biology
email

Recent publications

A Novel 167‐Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination
Advanced Science 2025cited by 7position: middledoi
LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
Cancer Gene Therapy 2024cited by 12position: lastdoi
Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research
Frontiers in Nutrition 2024cited by 8position: lastdoi
Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42
Cellular Signalling 2024cited by 7position: lastdoi
Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
Frontiers in Bioscience-Landmark 2024cited by 5position: middledoi
ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2
Cancer Gene Therapy 2024cited by 4position: lastdoi
Feedback loop LINC00511–YTHDF2–SOX2 regulatory network drives cholangiocarcinoma progression and stemness
MedComm 2024cited by 4position: middledoi
Circular <scp>RNA</scp> nuclear receptor interacting protein 1 promoted biliary tract cancer <scp>epithelial‐mesenchymal transition</scp> and stemness by regulating the <scp>miR</scp> ‐515‐5p/ <scp>AKT2</scp> axis and <scp>PI3K</scp> / <scp>AKT</scp> / <scp>mTOR</scp> signaling pathway
Environmental Toxicology 2023cited by 7position: lastdoi
Emerging roles of circ_NRIP1 in tumor development and cancer therapy (Review)
Oncology Letters 2023cited by 6position: lastdoi
PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1
Aging 2022cited by 29position: lastdoi
YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2
International Journal of Biological Sciences 2022cited by 26position: middledoi
Circular RNAs regulate parental gene expression: A new direction for molecular oncology research
Frontiers in Oncology 2022cited by 24position: middledoi
An Update on the Roles of circRNA-ZFR in Human Malignant Tumors
Frontiers in Cell and Developmental Biology 2022cited by 13position: lastdoi
Upregulation of circ_0059961 suppresses cholangiocarcinoma development by modulating miR-629-5p/SFRP2 axis
Pathology - Research and Practice 2022cited by 13position: lastdoi
Unveiling the prominent roles of circular RNAs ubiquitin binding associated protein 2 in cancers
Pathology - Research and Practice 2022cited by 1position: lastdoi
YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1
Aging 2021cited by 41position: lastdoi
Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis
Digestive Diseases and Sciences 2021cited by 20position: lastdoi
A Circular RNA, Cholangiocarcinoma‐Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers
Hepatology 2020cited by 233position: middledoi
SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN
Aging 2020cited by 46position: middledoi
LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis
Microvascular Research 2020cited by 44position: lastdoi
Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p
Human Cell 2020cited by 30position: middledoi
AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8
Aging 2020cited by 25position: firstdoi
Long noncoding RNA HOTAIRM1 in human cancers
Clinica Chimica Acta 2020cited by 20position: lastdoi
LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis
Pathology - Research and Practice 2020cited by 19position: lastdoi
PCAT1 induced by transcription factor YY1 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-216a-3p to up-regulate oncogene BCL3
Biological Chemistry 2020cited by 17position: lastdoi
Knockdown of lncRNA SNHG20 Suppressed the Proliferation of Cholangiocarcinoma by Sponging miR-520f-3p
Cancer Biotherapy and Radiopharmaceuticals 2020cited by 15position: lastdoi
Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation
Cancer Cell International 2020cited by 12position: middledoi
Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation
Research Square 2020cited by 1position: middledoi
The functions and mechanisms of BLACAT1 in malignant tumors
Zhongguo yishi zazhi 2020cited by 0position: lastdoi
Elevation of circular RNA circ_0005230 facilitates cell growth and metastasis via sponging miR-1238 and miR-1299 in cholangiocarcinoma
Aging 2019cited by 69position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yunfu Cui · Harbin Medical University32 papers (2014–2022)Zhenglong Li · Harbin Medical University20 papers (2017–2020)Xiangyu Zhong · Tohoku University20 papers (2014–2024)Yi Xu · Central South University19 papers (2017–2022)Pengcheng Kang · Harbin Medical University18 papers (2014–2025)Jinglin Li · Xi'an Jiaotong University18 papers (2017–2022)Canghai Guan · Harbin Medical University15 papers (2019–2025)Lining Huang · Harbin Medical University15 papers (2018–2021)Kaiming Leng · Qingdao University14 papers (2017–2020)Zhidong Wang · Harbin Medical University12 papers (2014–2023)Zengtao Hu · Harbin Medical University11 papers (2019–2021)Daolin Ji · Harbin Engineering University10 papers (2014–2020)Yuqiao Zhao · Harbin Medical University10 papers (2020–2022)Chunlong Li · Huazhong Agricultural University9 papers (2014–2020)Sheng Tai · Harbin Medical University8 papers (2014–2020)Zhilei Su · Central South University7 papers (2018–2020)Sidi Liu · University of Georgia7 papers (2022–2024)Lang Liu · Nanchang University7 papers (2020–2022)Dongsheng Sun · Harbin Medical University7 papers (2020–2023)Ming Wan · Harbin Medical University6 papers (2014–2017)